Projects

The aims of the ALLTogether study are to improve survival and quality of survival for children and young adults with ALL. ALL in young people has excellent outcome with >90% survival in children and about 75% in young adults. However, patients still die of diseases after relapse as a result of under-treatment.

Sleep apnea is a prevalent nocturnal breathing disorder and causes a high burden to the affected individuals, as well as to society and economy. However, current diagnostic methods for sleep apnea are complicated and labour-intensive processes involving various shortcomings related to measuring, analysing and reporting of data.

The PERAID project proposes to implement personalized medicine (PM) in severe infectious diseases, specifically focusing on the life-threatening necrotizing soft tissue infections (NSTI) as well as the large heterogeneous group of sepsis patients.

As the most commonly diagnosed malignancy and the 2nd leading cause of cancer-related death in men, prostate cancer (PC) is a major health care problem in the Nordic countries, where incidences will rise by 40% in the next 20-ys due to population aging.

Rheumatoid arthritis (RA, life-time risk around 2%) entails a considerable burden for affected individuals (pain, reduced life-span, reduced function, reduced quality of life), for health-care, and for society (reduced work ability, and treatment costs that currently accounts for almost 10% of the total drug expenditure). Delayed or ineffective treatment leads to joint destruction, co-morbidities, and increased mortality.v

The Nordic Society of Paediatric Haematology and Oncology (NOPHO), established in 1984, has been a successful and productive society leading to improved survival rates of childhood leukemias, Acute Lymphoblastic Leukemia (ALL) and Acute Myeloblastic Leukemia (AML).

Social conditions, such as income, employment and family resources, matter for health, and health matters for participation in society, employment and economic well-being. These associations are well known.